SATURDAY 6 MAY 2017
98
SCIENTIFIC PROGRAMME
| Programme and Exhibition Guide
in Breast Brachytherapy
H. Brastianos (Canada), T. Vaughan, A. Lasso, M. Westerland,
J. Gooding, T. Ungi, G. Fichtinger, C. Falkson
OC-0178
16:50 > Dosimetric impact of errors in HDR-iBT of the breast using a catheter
tracking method
C. Bert (Germany), M. Kellermeier, B. Hofmann, V. Strnad
OC-0179
17:00 > Prospective study of APBI With Multicatheter Brachytherapy in Local
Relapses of Breast Cancer
E. Villafranca Iturre (Spain), L. Rubi, M. Barrado, A. Sola, P. Navarrete,
A. Manterola, M. Dominguez, G. Asin, M. Campo, I. Visus, G. Martinez
OC-0180
17:10 > Long-term clinical and cosmetic outcomes of high-dose-rate
brachytherapy for early breast cancer
F. Arcidiacono (Italy), L. Chirico, M. Italiani, P. Anselmo, M. Casale,
L. Draghini, F. Trippa, S. Fabiani, M. Basagni, E. Maranzano
OC-0181
17:20 > 2nd breast conserving therapy with interstitial BT vs mastectomy for
treatment of local recurrences
V. Smanykó (Hungary), N. Mészáros, M. Ujhelyi, G. Stelczer, T. Major,
Z. Mátrai, C. Polgár
OC-0182
POSTER VIEWING 4
Brachytherapy miscellaneous
16:30 - 17:30 | POSTER AREA
Chair: D. Baltas (Germany)
Chair: L.U. Fokdal (Denmark)
> Microbrachytherapy: even more localised dose profiles?
R. Brown (France), X. Franceries, M. Bardiès
PV-0183
> Quantitative study on position margin in Intraluminal Brachytherapy
Planning for lung treatment
C.W. Kong (Hong Kong SAR China), H. Geng, Y.W. Ho, W.W. Lam,
K.Y. Cheung, S.K. Yu
PV-0184
> Retina dose as risk factor for worse visual outcome in 106Ru plaque
brachytherapy of uveal melanoma
G. Heilemann (Austria), L. Fetty, M. Blaickner, N. Nesvacil, D. Georg,
R. Dunavoelgyi
PV-0185
> MaxiCalc: a tool to calculate dose distributions from measured source
positions in HDR brachytherapy
M. Hanlon (Australia), R.L. Smith, R.D. Franich
PV-0186
> Source dwell time and transit time measurement for a HDR afterloading
unit
T.L. Chiu (Hong Kong SAR China), B. Yang, H. Geng, W.W. Lam,
C.W. Kong, K.Y. Cheung, S.K. Yu
PV-0187